# CLINICAL TRANSLATIONAL CORE

> **NIH NIH P50** · HUGO W. MOSER RES INST KENNEDY KRIEGER · 2022 · $283,284

## Abstract

PROJECT SUMMARY/ABSTRACT – CLINICAL TRANSLATIONAL CORE 
 The overall objective of the Clinical Translational Core (CTC) is to provide IDDRC-supported investigators 
access to resources that are critically important for the effective and efficient conduct of translational research 
of neurodevelopmental disorders. The CTC’s services range from cell culture studies, to preclinical animal 
services (animal behavior, histology, microscopy, mass spectrometry and molecular methods), to extensive 
clinical trial support, including consultation on protocol design and biostatistical analyses, pre-review prior to 
submission of protocols to the institutional review board (IRB), and hands-on advice and help with carrying out 
investigational protocols by experienced trialists, research coordinators and administrative staff. The Core’s 
directors and faculty members collectively have a high level of expertise across these services, as well as FDA 
regulatory expertise. The CTC will continue to support the movement of ideas and findings along the entire T4 
translational continuum. This reflects the Core’s and the Center’s shared commitment to enhancing the 
conversion of basic science discoveries into effective, commercially available disease-altering therapies; to 
provide scientific input towards public policy; and, ultimately, to improve outcomes for children and adults with 
intellectual and other developmental disabilities. 
 The objective of the Core will be achieved through the following Aims, which are to provide: (1) 
infrastructure and expertise needed to support projects focused on translation of basic science advances in the 
understanding of intellectual and developmental disabilities (IDD); (2) mentoring to assist IDD investigators in 
conducting clinical research and clinical trials; and (3) educational activities and dissemination opportunities.

## Key facts

- **NIH application ID:** 10450072
- **Project number:** 5P50HD103538-03
- **Recipient organization:** HUGO W. MOSER RES INST KENNEDY KRIEGER
- **Principal Investigator:** S. Ali Fatemi
- **Activity code:** P50 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $283,284
- **Award type:** 5
- **Project period:** 2020-08-01 → 2025-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10450072

## Citation

> US National Institutes of Health, RePORTER application 10450072, CLINICAL TRANSLATIONAL CORE (5P50HD103538-03). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10450072. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*